John Lauerman

Johnson & Johnson will pay as much $1.7 billion for V-Wave Ltd., bolstering its development efforts to treat heart failure as it goes deeper into medical technology.

Hi, it’s John in Boston, where the mpox epidemic in Africa appears to be a serious, but remote, problem. More on that below ...

Biohaven Ltd. shares rose sharply after its experimental drug slowed the progress of a rare nerve disease in a study, which the company will use to seek US approval later this year.

Apollo Global Management Inc. agreed to buy Barnes Group Inc. in an all-cash transaction that values the technology and aerospace manufacturer at about $3.6 billion.

The words “delay” and “depose” were written on a shell casing and a live round recovered in front of the New York Hilton Midtown, where UnitedHealth Group Inc. insurance chief Brian Thompson was fatally shot on Wednesday, according to people familiar with the matter.

Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by the blockbuster weight-loss drug Zepbound.

Apollo Global Management Inc.-owned packaging company Novolex said it will purchase rival Pactiv Evergreen Inc. for $18 a share, or $6.7 billion including debt.

Keros Therapeutics Inc. shares plunged after the biotech company halted dosing for some patients in a mid-stage trial of its lung disorder drug over side effect concerns.

H&E Equipment Services has ended its previous agreement with United Rentals Inc. to accept a higher offer from Herc Holdings Inc., a statement from Herc confirmed Tuesday.

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells using using the same gateway as the virus that causes Covid-19.